Hepaglide 0.25 mg Injection is a weekly subcutaneous,, prescription-based, semaglutide-based medication used to manage type 2 diabetes, obesity, and weight loss. It is a GLP-1 receptor agonist that acts by lowering blood sugar, slowing digestion, and reducing appetite and typically supplied in a prefilled multi-dose pen with needles.